ATHEROSCLEROSIS RISK FACTORS INFLUENCE ENDOTHELIAL MICROVESICLE COUNT IN PERIPHERAL BLOOD

Vytautas Žėkas1, Reda Matuzevičienė1, Dovilė Karčiauskaitė1, Asta Mažeikienė1, Neringa Burokienė1, Mantas Radzevičius1, Aušra Janulionienė2, prof. Zita Aušrelė Kučinskienė1

1 Departament of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio str. 21/27, LT-03101 Vilnius, Lithuania.

2 Center for Laboratory Medicine, Vilnius University Hospital Santariškių Clinics, Santariškių str. 2, LT-08661 Vilnius

High numbers of circulating microvesicles of different cell origin have been associated with subclinical atherosclerosis. Microvesicles shed from endothelial cell may participate in the pathogenesis of oxidative stress, inflammation, coagulation and angiogenesis [1]. The objective of this study was to test the relationship between known atherosclerosis risk factors and counts of two different populations of endothelial microvesicles (EMV). We included 81 male individuals in the study aged between 25 and 55 years who were apparently healthy or without any acute clinical condition. Informed consent was obtained from all the subjects and the study protocol was approved by the local ethics committee of Vilnius University. Laboratory tests including concentration of C-reactive protein, glucose, total cholesterol, triglycerides, HDL- and LDL-cholesterol were performed using routine techniques. Fresh blood samples were collected in Lithium and Sodium Heparin contained tubes after night fasting. Tubes were centrifuged for 10 minutes at 3000g within one hour from collection to obtain platelet free plasma (PPP). Three quarters of said plasma were transferred to sterile tube and centrifuged again at 15000g for 30 minutes in angle head motor to pellet microvesicles. Resulting EMV pellet was reconstituted with 1ml serum free freezing medium containing DMSO (Biological Industries, Israel) and analyzed by flow cytometry. All samples were labeled with anti CD144-FITC, anti CD105-BV421, anti CD42a-PerCP, anti CD62e-PE, anti CD31-APCy7, anti CD61-APC (BD, San Jose) and tested using BD Fortessa cytometer (BD, San Jose). All events were gated by forward and side light scatter parameters. In our research we examined two endothelial microvesicle (EMV) populations: 1) expressing CD144, CD42b-, CD61- and 2) CD105, CD42b-, CD61- markers. Furthermore in each population we determined a percentage of EMVs, expressing CD62e. The men were grouped according to their blood pressure: 1) having blood pressure equal to or more than 140 mm/Hg (n=17); 2) having blood pressure less than 140 mm/Hg (n=64). Percentage of EMVs expressing CD 144 and CD62e was significantly higher in group with higher blood pressure (d=8.24%±4.67 vs d=5.20%±3.36, P=0,03). We also have found significant positive correlation with diastolic blood pressure (d=79.94±8.84, P<0.001), total cholesterol (d=5.84±3.85, P<0.001) and triglycerides concentration (P<0.001), especially with the microvesicles, expressing CD62e. The results of this study suggest a strong direct association between different atherosclerosis risk factors and EMV count in peripheral plasma of apparently healthy individuals.


[1] R. P. Keshav, P. Nisha, K. Dong-Wook. Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression. Scientifica 2016:9 (2016)